Global Prenatal and Maternal Diagnostic Market Sees CAGR 18% till 2020

The global prenatal and maternal diagnostic market includes a non-invasive series of prenatal screening tests. This industry will see a rise at CAGR 18% till 2020. In the prenatal diagnostic market, the expense is more in chorionic villus sampling, amniocentesis, and other surgical methods. The global maternal, prenatal, and newborn diagnostic screening test market will be worth more than $10.5 billion, which stands today at $8 billion. Maternal blood also reveals a lot about the woman’s and the unborn health.

Because of advanced genetic protocol and screening tests, it is possible to detect maternal complications or progress. Due to such steps, a lot many lives are saved. If treating an abnormal fetus growth or disease is needed, the diagnostics will aid doctors decide a treatment plan. Both the life expectancy of child and mother has improved with newer models in testing and analysis of diseases.

What are the Diagnostics in Prenatal Stage?

The platform is divided on fetal MRI, ultrasound, non-invasive screening technologies, maternal serum etc. These will have 4.1% growth rate in the next five years, as per medical market research. When DNA sequencing proved a success, the focus was shifted to treatment of genetic diseases. The need of remedies led to more experiments and advancements in pre-implantation genetic diagnosis, in vitro fertilization, fetal ultrasound tests, and modern prenatal tests etc.

How is Genetics Technology Helping Parents?

Intention behind such techniques is to detect genetic fault in fetuses, newborns, and embryos. The goal is to aid treatment of pregnancy disorders, structural chromosome diseases, numerical chromosome disorders, and single gene conditions inherited by the newborn, embryo or the fetus. The maternal diagnostic market is segregated as newborn screening, NIIPT, prenatal MRI etc. Emerging trends for relevant market is based on molecular diagnostics, in vitro techniques, liquid biopsy, and others.